- FSTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
F-star Therapeutics (FSTX) S-3Shelf registration
Filed: 1 Jun 17, 12:00am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of Spring Bank Pharmaceuticals, Inc. of our report dated February 14, 2017, relating to the consolidated financial statements of Spring Bank Pharmaceuticals, Inc. and its subsidiaries, appearing in the Annual Report on Form 10-K of Spring Bank Pharmaceuticals, Inc. for the year ended December 31, 2016.
We also consent to the reference to our firm under the heading “Experts” in the Prospectus, which is part of the Registration Statement.
/s/ RSM US LLP
Boston, Massachusetts
June 1, 2017
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.